Free Trial
LON:KP2

Kore Potash (KP2) Share Price, News & Analysis

GBX 2.30 0.00 (0.00%)
(As of 12/24/2024 06:51 AM ET)

About Kore Potash Stock (LON:KP2)

Key Stats

Today's Range
2.21
2.30
50-Day Range
2.20
4.40
52-Week Range
0.45
4.50
Volume
116,865 shs
Average Volume
2.80 million shs
Market Capitalization
£100.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Kore Potash plc, together with its subsidiaries, engages in the exploration and development of potash minerals in the Republic of Congo. It holds 97% interest in Sintoukola Potash project that comprises the Kola sylvinite and carnallite deposits, as well as DX sylvinite deposits and Dougou carnallite deposits located in the north of the city of Pointe Noire. Kore Potash plc was incorporated in 2017 and is based in London, the United Kingdom.

Receive KP2 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kore Potash and its competitors with MarketBeat's FREE daily newsletter.

KP2 Stock News Headlines

Kore Potash Share Price (KP2)
Kore Potash Ltd DRC (KP2)
See More Headlines

KP2 Stock Analysis - Frequently Asked Questions

Kore Potash's stock was trading at GBX 0.60 at the beginning of the year. Since then, KP2 stock has increased by 283.3% and is now trading at GBX 2.30.
View the best growth stocks for 2024 here
.

Shares of KP2 stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Kore Potash investors own include AutoZone (AZO), Intel (INTC), Lockheed Martin (LMT), Northrop Grumman (NOC), TJX Companies (TJX), Abacus Health Products (ABAHF) and Adaptimmune Therapeutics (ADAP).

Industry, Sector and Symbol

Industry
Other Industrial Metals & Mining
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
21
Year Founded
N/A

Profitability

Net Income
£-1,150,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
GBX 4 per share

Miscellaneous

Outstanding Shares
4,350,000,000
Free Float
N/A
Market Cap
£100.05 million
Optionable
Not Optionable
Beta
1.31
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (LON:KP2) was last updated on 12/25/2024 by MarketBeat.com Staff
From Our Partners